Vanquish Oncology, Inc.
Records under this name other than patents Vanquish Oncology, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 10 of 10 · Back to Vanquish Oncology, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,399,035 | Procaspase 3 Activation by Combination Therapy In force · High confidence | In force | High confidence | |
| US 9,421,202 | Procaspase Combination Therapy for Glioblastoma In force · High confidence | In force | High confidence | |
| US 10,085,977 | Procaspase 3 Activation by Combination Therapy In force · Medium confidence | In force | Medium confidence | |
| US 10,085,978 | Procaspase Combination Therapy for Glioblastoma now held by The Johns Hopkins University In force · High confidence | In force | High confidence | |
| US 10,874,666 | Procaspase Combination Therapy for Glioblastoma In force · High confidence | In force | High confidence | |
| US 10,888,560 | Procaspase 3 Activation by Combination Therapy In force · Low confidence | In force | Low confidence | |
| US 11,844,798 | Procaspase Combination Therapy for Glioblastoma In force · High confidence | In force | High confidence | |
| US 12,433,885 | Procaspase Combination Therapy for Glioblastoma In force · High confidence | In force | High confidence | |
| US 9,592,229 | Potent Anticancer Activity via Dual Compound Activation In force · High confidence | In force | High confidence | |
| US 11,833,147 | Procaspase 3 Activation by Combination Therapy In force · Medium confidence | In force | Medium confidence |